Therapy-related acute promyelocytic leukemia

Journal of Clinical Oncology

Volumn 21, Issue 11, 2003, Pages 2123-2137

  Beaumont, M ^b   Sanz, M ^b   Carli, P M ^b   Maloisel, F ^b   Thomas, X ^b   Detourmignies, L ^b   Guerci, A ^b   Gratecos, N ^b   Rayon, C ^b   San Miguel, J ^b   Odriozola, J ^b   Cahn, J Y ^b   Huguet, F ^b   Vekhof, A ^b   Stamatoulas, A ^b   Dombret, H ^b   Capote, F ^b   Esteve, J ^b   Stoppa, A M ^b   Fenaux, P ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYTARABINE; DNA TOPOISOMERASE INHIBITOR; EPIPODOPHYLLOTOXIN DERIVATIVE; MITOXANTRONE; ANTINEOPLASTIC ANTIBIOTIC; DNA TOPOISOMERASE (ATP HYDROLYSING); RETINOIC ACID;

ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SOLID TUMOR; ADULT; AGED; BELGIUM; BREAST TUMOR; CHILD; FEMALE; FRANCE; GENETICS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SPAIN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BELGIUM; BREAST NEOPLASMS; CHILD; DNA TOPOISOMERASES, TYPE II; FEMALE; FRANCE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKEMIA, RADIATION-INDUCED; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME; TRETINOIN;

EID: 0037868159     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.09.072     Document Type: Article

References (62)

1. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, et al: Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99:1909-1912, 2002
2. Pedersen-Bjergaard J, Philip P, Larsen SO, et al: Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083-1091, 1990
3. Quesnel B, Kantarjian H, Pedersen-Bjergaard J, et al: Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): A report on 25 cases and review of the literature. J Clin Oncol 11:2370-2379, 1993
4. Pedersen-Bjergaard J, Andersen MK, Christiansen DH: Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 95:3273-3279, 2000
5. Sterkers Y, Preudhomme C, Lai JL, et al: Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: High proportion of cases with 17p deletion. Blood 91:616-622, 1998
6. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the acute leukaemias: French-American-British (FAB) Co-operative Group. Br J Haematol 33:451-458, 1976
7. Bennett JM, Catovsky D, Daniel MT, et al: A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 92:261, 1980
8. Melnick A, Licht JD: Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215, 1999
9. Tallman MS: The thrombophilic state in acute promyelocytic leukemia. Semin Thromb Hemost 25:209-215, 1999
10. Chomienne C, Ballerini P, Balitrand N, et al: All-trans retinoic acid in acute promyelocytic leukemias: II. In vitro studies: Structure-function relationship. Blood 76:1710-1717, 1990
11. Fenaux P, Degos L: Differentiation therapy for acute promyelocytic leukemia. N Engl J Med 337:1076-1077, 1997
12. Fenaux P, Chomienne C, Degos L: Treatment of acute promyelocytic leukaemia. Best Pract Res Clin Haematol 14:153-174, 2001
13. Bennett M: A case of myelocytic leukemia simulating the mouse model diseases. J Surg Oncol 2:239-243, 1970
14. Auclerc G, Jacquillat C, Auclerc MF, et al: Post-therapeutic acute leukemia. Cancer 44:2017-2025, 1979
15. Amadori S, Papa G, Anselmo AP, et al: Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease. Cancer Treat Rep 67:603-604, 1983
16. Garson OM, Hagemeijer A, Kondo K, et al: Fourth International Workshop on Chromosomes in Leukemia 1982: Chromosomes in acute promyelocytic leukemia. Cancer Genet Cytogenet 11:288-293, 1984
17. Papa G, Mauro FR, Anselmo AP, et al: Acute leukaemia in patients treated for Hodgkin's disease. Br J Haematol 58:43-52, 1984
18. Michels SD, McKenna RW, Arthur DC, et al: Therapy-related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases. Blood 65:1364-1372, 1985
19. Le Beau MM, Albain KS, Larson RA, et al: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4:325-345, 1986
20. Kanakura Y, Yonezawa T, Hamaguchi Y, et al: Acute promyelocytic leukemia with an intracerebral mass and meningeal involvement after treatment of non-Hodgkin's lymphoma. Cancer 59:94-98, 1987
21. Whang-Peng J, Young RC, Lee EC, et al: Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 71:403-414, 1988
22. Fenaux P, Lucidarme D, Lai JL, et al: Favorable cytogenetic abnormalities in secondary leukemia. Cancer 63:2505-2508, 1989
23. Fenaux P, Detourmignies L: Therapy-related acute promyelocytic leukaemia. Br J Haematol 87:445-446, 1994
24. Detourmignies L, Castaigne S, Stoppa AM, et al: Therapy-related acute promyelocytic leukemia: A report on 16 cases. J Clin Oncol 10:1430-1435, 1992
25. Pogliani EM, Bregani ER, Mangiagalli M, et al: Therapy-related acute promyelocytic leukemia. Leukemia 7:1679-1687, 1993
26. Richards EM, Marcus RE: Acute promyelocytic leukaemia following radioiodine therapy. Clin Lab Haematol 15:55-58, 1993
27. Bhavnani M, Azzawi SA, Yin JA, et al: Therapy-related acute promyelocytic leukaemia. Br J Haematol 86:231-232, 1994
28. Matsuzaki A, Inamitsu T, Watanabe T, et al: Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis. Br J Haematol 86:887-889, 1994
29. Gillis S, Sofer O, Zelig O, et al: Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease: A report of 4 cases. Ann Oncol 6:777-779, 1995
30. Hoffmann L, Moller P, Pedersen-Bjergaard J, et al: Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II: A report of two cases and a review of the literature. Ann Oncol 6:781-788, 1995
31. Wiernik PH, Muse IM: Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: Case report and review of the literature. Leukemia 10:178-182, 1996
32. Pollicardo N, O'Brien S, Estey EH, et al: Secondary acute promyelocytic leukemia: Characteristics and prognosis of 14 patients from a single institution. Leukemia 10:27-31, 1996
33. Vicari AM, Ciceri F, Folli F, et al: Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia 12:441-442, 1998
34. De Renzo A, Santoro LF, Notaro R, et al: Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II. Am J Hematol 60:300-304, 1999
35. Haupt R, Fears TR, Heise A, et al: Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. Int J Cancer 71:9-13, 1997
36. Elezovic I, Colovic M, Tomin D, et al: Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: A case report. Med Oncol 17:222-224, 2000
37. Andersen MK, Larson RA, Mauritzson N, et al: Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 33:395-400, 2002
38. Lai JL, Fenaux P, Zandecki M, et al: Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17). Cancer Genet Cytogenet 29:311-314, 1987
39. Fenaux P, Castaigne S, Dombret H, et al: All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80:2176-2181, 1992
40. Fenaux P, Le Deley MC, Castaigne S, et al: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: Results of a multicenter randomized trial European APL 91 Group. Blood 82:3241-3249, 1993
41. Fenaux P, Chastang C, Chevret S, et al: A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the rôle of maintenance therapy in newly diagnosed acute promyelocytic leukemia: The European APL Group. Blood 94:1192-1200, 1999
42. Sanz MA, Lo-Coco F, Martin G, et al: Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253, 2000
43. Sanz MA, Martin G, Rayon C, et al: A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR alpha-positive acute promyelocytic leukemia. Blood 94:3015-3021, 1999
44. Chaplain G, Milan C, Sgro C, et al: Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: A population-based study. J Clin Oncol 18:2836-2842, 2000
45. Kantarjian HM, Keating MJ, Walters RS, et al: The association of specific "favorable" cytogenetic abnormalities with secondary leukemia. Cancer 58:924-927, 1986
46. Marty M, Ganem G, Fischer J, et al: Acute promyelocytic leukemia: Retrospective study of 119 patients treated with daunorubicin. Nouv Rev Fr Hematol 26:371-378, 1984
47. Cunningham I, Gee TS, Reich LM, et al: Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital. Blood 73:1116-1122, 1989
48. Fenaux P, Pollet J, Vandenbossche L, et al: Treatment of acute promyelocytic leukemia: A report on 70 cases. Leuk Lymphoma 4:239-248, 1991
49. Beaumont M, Laï JL, Simonnet E, et al: Therapy related acute promyelocytic leukemia (tAPL): Increasing incidence, especially after non Hodgkin's lymphoma (NHL) treated intensively? Blood 96:321a, 2000
50. Dumontet C, Bastion Y, Felman P, et al: Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. Ann Oncol 3:639-644, 1992
51. Egeler RM, Neglia JP, Arico M, et al: The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors: The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 12:369-378, 1998
52. Saso R, Kulkarni S, Mitchell P, et al: Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 83:91-94, 2000
53. Carli PM, Sgro C, Parchin-Geneste N, et al: Increase therapy-related leukemia secondary to breast cancer. Leukemia 14:1014-1017, 2000
54. Linassier C, Barin C, Calais G, et al: Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 11:1289-1294, 2000
55. Curtis RE, Boice JD Jr, Stovall M, et al: Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745-1751, 1992
56. Biondi A, Rovelli A, Cantu-Rajnoldi A, et al: Acute promyelocytic leukemia in children: Experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 8:S66-S70, 1994
57. Lakhani S, Davidson RN, Hiwaizi F, et al: Razoxane and leukaemia. Lancet 2:288-289, 1984
58. The French Langerhans' Cell Histiocytosis Study Group: A multicentre retrospective survey of Langerhans' cell histiocytosis-348 cases observed between 1983 and 1993: The French Langerhans' Cell Histiocytosis Study Group. Arch Dis Child 75:17-24, 1996
59. Kudo K, Yoshida H, Kiyoi H, et al: Etoposide-related acute promyelocytic leukemia. Leukemia 12:1171-1175, 1998
60. Xue Y, Lu D, Guo Y, et al: Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis. Leuk Res 16:1113-1123, 1992
61. De Botton S, Chevret S, Sanz M, et al: Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: Results of APL 93 trial. Br J Haematol 111:801-806, 2000
62. Naoe T, Kudo K, Yoshida H, et al: Molecular analysis of the t(15; 17) translocation in de novo and secondary acute promyelocytic leukemia. Leukemia 11:287-288, 1997 (suppl 3)